|

Pancreatic Cancer Detection Consortium

RECRUITINGSponsored by City of Hope Medical Center
Actively Recruiting
SponsorCity of Hope Medical Center
Started2023-03-15
Est. completion2026-06-18
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations9 sites
View on ClinicalTrials.gov →

NCT06388967

Summary

This study aims to prospective validate an exosome-based miRNA signature for noninvasive and early detection of pancreatic ductal adenocarcinoma.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Histological diagnosis of pancreatic ductal adenocarcinoma, stages I-IV (TNM classification, 8th edition)
* Received standard diagnostic and staging procedures as per local guidelines, and at least one sample was drawn before receiving any curative-intent treatment.
* Imaging- or endoscopy-based proof of lack of pancreatic ductal adenocarcinoma at the time of sampling (Non-disease controls)

Exclusion Criteria:

* Lack of written informed consent.

Conditions14

CancerPancreatic AdenocarcinomaPancreatic CancerPancreatic Cancer Non-resectablePancreatic Cancer ResectablePancreatic Cancer StagePancreatic Cancer Stage 0Pancreatic Cancer Stage IPancreatic Cancer Stage IIPancreatic Cancer Stage III

Locations9 sites

Translational Genomics Research Institute
Phoenix, Arizona, 85004
Daniel Von Hoffdvh@tgen.org
Honorhealth
Scottsdale, Arizona, 85258
Erkut Borazancierkut.borazanci@honorhealth.com
City of Hope Medical Center
Monrovia, California, 91016
Ajay Goel, PhD626-218-3452AJGOEL@COH.ORG
Hoag Center
Newport Beach, California, 92663
Michael Demeuremichael.demeure@hoag.org
OSF HealthCare
Peoria, Illinois, 61637
Chandler Wilfongchandler.d.wilfong@osfhealthcare.org

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.